Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis.

Annals of the rheumatic diseases - 1 Apr 2005

Schotte H, Schlüter B, Drynda S, Willeke P, Tidow N, Assmann G, Domschke W, Kekow J, Gaubitz M

Abstract excerpt

OBJECTIVES: To analyse the association of interleukin 10 (IL10) promoter polymorphisms, which have been shown to be related to IL10 secretion capacity, with the response to long term treatment with etanercept in patients with rheumatoid arthritis (RA). METHODS: Fifty patients with active RA were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Arthritis, Rheumatoid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance

Share to Etanercept

Share to Immunoglobulin G

Share to Interleukin-10

Share to Receptors, Tumor Necrosis Factor

Share to Tumor Necrosis Factor-alpha

Source

Open in PubMed Open full text

Identifiers

PMID: 15345504
DOI: 10.1136/ard.2004.027672
PMCID: PMC1755447

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15345504-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis.PMID 15345504Read ↗

Putative IL-10 Low Producer Genotypes Are Associated with a Favourable Etanercept Response in Patients with Rheumatoid Arthritis.Semantic proximity Read ↗

Interleukin-6 promoter haplotypes are associated with etanercept response in patients with rheumatoid arthritis.Semantic proximity Read ↗

Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune response.Semantic proximity Read ↗

IL10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patients.Semantic proximity Read ↗

Interleukin-10 promoter polymorphism in patients with rheumatoid arthritisSemantic proximity Read ↗

Influence of interleukin 10 promoter polymorphisms in polymyalgia rheumatica: disease susceptibility and functional consequences.Semantic proximity Read ↗

The role of interleukin 10 promoter polymorphisms in the susceptibility of distal interphalangeal osteoarthritis.Semantic proximity Read ↗

A functional variant of TLR10 modifies the activity of NFkB and may help predict a worse prognosis in patients with rheumatoid arthritis.Semantic proximity Read ↗

Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis.Semantic proximity Read ↗

Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis.Semantic proximity Read ↗

Interleukin 10 polymorphisms in ankylosing spondylitis.Semantic proximity Read ↗

Interleukin-1?, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: Relationship to occurrence and severity of rheumatoid arthritisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.